Dr. Robert Feldman Slifkin, M.D. Internal Medicine - Nephrology Medicare: Not Enrolled in Medicare Practice Location: 1234 The Knl, Oyster Bay, NY 11771 Phone: 516-626-8947 Fax: 516-626-0496 |
News Archive
People who have suspected idiopathic pulmonary fibrosis without typical patterns on high resolution computed tomography scans could in future be spared the substantial risks of lung biopsy and be given a confident diagnosis of IPF based on clinical and radiological findings alone, according to new research published in The Lancet Respiratory Medicine.
To some, the idea of invisibility leads to mischief, seeing things without being seen. To the pathologist, the idea of invisibility leads to simplicity, seeing the disease in its fullest.
Lack of exercise is killing people. People who prefer the couch to the track are more at risk for obesity, diabetes, cancer and heart disease to name just a few results of a sedentary lifestyle. But what motivates people to get moving?
Elektron Technology is launching a new, easy-to-use macular pigment screener (MPS II) that can quickly identify those most at risk of developing age-related macular degeneration (AMD).
Exelixis, Inc. today reported long-term results in a cohort of 37 medullary thyroid cancer (MTC) patients who participated in the phase 1 study of XL184. Dr. Razelle Kurzrock from the MD Anderson Cancer Center in Houston, TX will present the data in a Clinical Science Symposium (Abstract #5502) on Monday, June 7 at 10:15 AM at the 2010 Annual Meeting of the American Society of Clinical Oncology in Chicago.
› Verified 4 days ago